To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Animal Antibiotics and Antimicrobials Market size was valued at USD 4.32 billion in 2021 and is poised to grow from USD 4.47 billion in 2022 to USD 5.89 billion by 2030, growing at a CAGR of 3.5% in the forecast period (2023-2030).

The competitive landscape is shaped by various factors, including research and development activities, technological advancements, pricing strategies, and marketing initiatives. Key market players focus on product innovation and development to meet the evolving needs of the veterinary healthcare sector. They invest significantly in research to develop new antibiotic formulations and alternative antimicrobial agents that are effective and safe for animal use. 'Zoetis Inc. (United States)', 'Merck Animal Health (United States)', 'Elanco Animal Health (United States)', 'Boehringer Ingelheim Animal Health (Germany)', 'Ceva Santé Animale (France)', 'Vetoquinol S.A. (France)', 'Bayer Animal Health (Germany)', 'Virbac (France)', 'Dechra Pharmaceuticals (United Kingdom)', 'Norbrook Laboratories Ltd. (United Kingdom)', 'Huvepharma (Bulgaria)', 'Phibro Animal Health Corporation (United States)', 'China Animal Husbandry Co., Ltd. (China)', 'Hester Biosciences Limited (India)', 'Indian Immunologicals Ltd. (India)', 'Hipra (Spain)', 'Bimeda Holdings Plc (Ireland)', 'Kyoritsu Seiyaku Corporation (Japan)', 'Vétoquinol (Japan)', 'Ouro Fino Saúde Animal (Brazil)'

The occurrence of infectious diseases among animals, such as avian influenza, foot-and-mouth disease, and swine fever, underscores the necessity of using antibiotics and antimicrobials to control and prevent the spread of diseases. The potential economic losses associated with disease outbreaks drive the demand for these products, particularly in regions where the prevalence of such diseases is high. This demand stems from the need to protect animal health and maintain productivity within the livestock industry.

Growing Emphasis on Antibiotic Alternatives and Responsible Use of Antimicrobials. With the rising concerns over antimicrobial resistance (AMR) and its impact on human and animal health, there is a shift towards reducing the use of antibiotics in animal production. This trend is driven by regulatory initiatives, consumer awareness, and a push from industry stakeholders to find effective alternatives that promote animal health while minimising the risk of AMR. Antibiotic alternatives such as probiotics, prebiotics, phytogenics, and vaccines are gaining traction as viable options to maintain animal health and improve performance.

Analysing the regional insights of the animal antibiotics and antimicrobials market, the most dominant region is North America. The region has a well-established animal agriculture industry and stringent regulations governing the use of antibiotics and antimicrobials in animal health. The North American market is characterised by the presence of major market players, advanced veterinary healthcare infrastructure, and a high level of awareness regarding animal health and welfare. These factors contribute to the dominance of North America in the Animal Antibiotics and Antimicrobials market.

Feedback From Our Clients

Global Animal Antibiotics and Antimicrobials Market

Product ID: SQMIG35A2329